There is a clear link between the intensity of cell proliferation and susceptibility to neoplasia.' 2 In the large intestine, surgical or dietary manipulations that stimulate cell growth generally promote experimental colorectal carcinogenesis, [3] [4] [5] whereas mucosal hypoplasia (for example, by defunctioning colostomy) has a protective effect. 6 Patients with colonic adenoma or carcinoma show increased labelling indices in 'normal' biopsy specimens taken from multiple sites,7 and those with ulcerative proctocolitis have increased crypt cell proliferation even in quiescent disease.8 Thus, the cytokinetic status of the epithelium9'0 could reflect a subject's susceptibility to colorectal neoplasia.
Calcium may protect against colorectal cancer by reducing epithelial cell turnover."12 Vitamin D could be another chemopreventative agent '3 because of its ability to switch cellular activity (in various cancer cell lines) from proliferation to differentiation.'>6 In particular, the human colon cancer cell lines HT-29'7 '1 and LOVO'4 possess high affinity receptors for the active metabolite ofvitamin D3 (1,25 (OH)2 D3), which suppresses cell growth and induces changes indicative of differentiation. Receptors Rectal biopsy specimens were divided into tiny explants and orientated mucosal surface uppermost on a metal grid within an organ culture dish (Lux Laboratories). Explants were cultured as paired samples in standard culture medium (CMRL 1066, Gibco, Paisley, UK) or in standard culture medium to which vitamin D metabolites had been added: 1,25 (OH)2 D3 at concentrations of 1 F,M (10-6 M), 10 nM (10-8 M), or 100 pM (10-'0 M); ergocalciferol (vitamin D2) at 10 nM (10-8 M); and calcipotriol (MC-903) at 100 mM (10 M). Thus each biopsy specimen acted as its own control. The concentrations of vitamin D chosen were in a similar range to previous studies,"'8 and the lowest dose of 1,25 (OH)2 D3 is probably within the human physiological range. In total, 34 biopsy specimens were obtained from controls and 10 from familial adenomatous polyposis patients, and each biopsy was divided into several explants (between six and 15). HT-29 cells were maintained as a monolayer of cells in Dulbecco's modified Eagle's medium (DMEM, Flow Laboratories, High Wycombe, UK) with 10% fetal calf serum, 100 U/ml penicillin, and 100 ,ug/ml streptomycin (Serolabs, Crawley, UK). Cells were incubated at 37°C in 95% 02 and 5% C02, and the medium was changed every 2 days. At 80-90% visual confluence, the cells were trypsinised with 0.25% trypsin and EDTA (Flow Laboratories).
After washing in phosphate buffer saline (PBS), aliquots of 1 x 10 cells were added to a six well tissue culture plate (Gibco). The cells were cultured in DMEM, with or without the addition of calcipotriol (MC-903) at a final concentration of 10-to 10-9 M. All plates were set up in quadruplicate.
After viability assessment using trypan blue exclusion, the total cell number was determined at 7, 14, and 21 days by counting at least three samples from each concentration using a haemocytometer. Results were analysed using one way analysis of variance and the Mann-Whitney U test.
Results

ORGAN CULTURE
The overall mean (SEM) crypt cell production rate (CCPR) in 17 normal patients (Figure) (SEM) ). Calcipotriol produced a clearcut dose dependent inhibition of proliferation. After 21 days' culture calcipotriol reduced the number of cells to 0-06% of the control value at 10-5 M (p<0 01), to 0-11% at 10-6 M (p<0 01), to 8-45% at 10-7 M (p<0 001), and to 94 10% at 1-8 M (see Table) . '4 Irrespective of the mode of action, vitamin D, its metabolites and analogues inhibit colonic epithelial proliferation, at least in vitro. In premalignant conditions associated with an accelerated epithelial cell proliferation, a reduction in CCPR might be beneficial. 
